Skip to main content
Clinical Trials/NCT00323843
NCT00323843UnknownPhase 2

RIRS - A Method of Treating the ESWL Resistant Kidney Stone

Fredericia Hosptial2 sites in 1 country10 target enrollmentStarted: June 1, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 2
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Renal pelvic pressure

Study Overview

Brief Summary

Is it possible to decrease the intrarenal pressure in the kidney during endoscopic management of kidney stone by topical administration of drugs? In order to secure fewer complications in ureteroscopic operations the pharmacological agent isoproterenol is tested on pigs and human to determine its potential of lowering intrarenal pressure.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Indication for RIRS procedure
  • Age > 18 years
  • Normotensive
  • Capable of understanding information given

Exclusion Criteria

  • Previous myocardiac infarct
  • Daily use of alpha- og beta- blocking medicine og calcium antagonists
  • Use of NSAID the last 2 days
  • Stone in the ureter
  • Known malignant disease in urinary tract
  • Bladder disease
  • Nephrostomies inserted
  • JJ-catheters inserted
  • Prisoners
  • Nursing mothers

Outcomes

Primary Outcomes

Renal pelvic pressure

Secondary Outcomes

  • Blood pressure
  • Pulse

Investigators

Sponsor
Fredericia Hosptial
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials